Nuclear Medicine
FLUORIDE
Name:
Oseopet Radiofarma
Active Principle:
Sodium Fluoride (18F)
Therapeutic Action:
It is indicated for the evaluation of areas of altered osteogenic activity in recurrent or metastatic primary disease of various tumors.
Nuclear Medicine
FLUORIDE
Name:
Oseopet Radiofarma
Active Principle:
Sodium Fluoride (18F)
Therapeutic Action:
It is indicated for the evaluation of areas of altered osteogenic activity in recurrent or metastatic primary disease of various tumors.
RELATED PRODUCTS
-
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
AV45 (R+D)
AV45 (R+D)It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive... -
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test.

